Despite advancements in asthma treatments that could save lives, structural barriers prevent equitable access, leaving many patients at risk. Recent federal actions against diversity in health research are hindering the pursuit of critical studies to understand asthma disparities, particularly concerning race and gender. The restrictions threaten to reverse progress in treating severe asthma effectively. The authors argue that censoring scientific inquiry into health equity not only endangers lives but also undermines the integrity and innovation of the medical field in America, where diversity in clinical trials is essential for comprehensive care.
In recent weeks, studies that would help us answer these and other health equity questions have come under attack from the federal government for their wokeness and shameful agenda.
Censoring research on how to deliver treatments to those most in need isn't just nonsensical; it puts lives at risk and undermines America's leadership in medical innovation.
Collection
[
|
...
]